phenytoin has been researched along with myelin oligodendrocyte glycoprotein (35-55) in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Black, JA; Carrithers, LM; Carrithers, M; Liu, S; Waxman, SG | 1 |
| Black, JA; Liu, S; Waxman, SG; Zwinger, P | 1 |
2 other study(ies) available for phenytoin and myelin oligodendrocyte glycoprotein (35-55)
| Article | Year |
|---|---|
Exacerbation of experimental autoimmune encephalomyelitis after withdrawal of phenytoin and carbamazepine.
Topics: Animals; Anticonvulsants; Antigens, CD; Axons; Carbamazepine; Cell Count; Disease Models, Animal; Encephalomyelitis, Autoimmune, Experimental; Flow Cytometry; Gene Expression Regulation; Glycoproteins; Mice; Mice, Inbred C57BL; Myelin-Oligodendrocyte Glycoprotein; NAV1.6 Voltage-Gated Sodium Channel; Nerve Tissue Proteins; Peptide Fragments; Phenytoin; Pyramidal Tracts; Severity of Illness Index; Sodium Channels; Substance Withdrawal Syndrome | 2007 |
Tapered withdrawal of phenytoin removes protective effect in EAE without inflammatory rebound and mortality.
Topics: Animals; Disease Models, Animal; Drug Administration Schedule; Encephalomyelitis, Autoimmune, Experimental; Mice; Mice, Inbred C57BL; Myelin-Oligodendrocyte Glycoprotein; Neurologic Examination; Neuroprotective Agents; Peptide Fragments; Phenytoin; Time Factors | 2014 |